Administering medicines by injection
Empowering pharmacists for emerging health needs
The Administering Medicines by Injection Course
Build your confidence and competence in administering medicines by injection, empowering you to provide integrated patient care, and enabling patients to have greater access to safe administration of medicines.
PSA has developed the Guidelines for pharmacists administering medicines by injection and is the only provider of education and training required for pharmacists to administer medicines by injection.
Please note: this online course is designed for trained and authorised pharmacist immunisers to continue professional development and upskill in administering medicines by injection.
Guidelines relevant to administering medicines by injection include the Guidelines for pharmacists administering medicines by injection and the Practice guidelines for the provision of immunisation services.
PSA are custodians of a range of Guidelines to support pharmacists in practice.
The authority and recognition of the pharmacist’s role in administering medicines by injection, is provided by jurisdictional legislation and may vary nationally.
Pharmacists must meet relevant legislative requirements for the State or Territory in which they practise, to administer medicines by injection.
Currently pharmacists are permitted (with conditions) to administer medicines by injection in the Australian Capital Territory, New South Wales, Tasmania and Victoria. Long-acting buprenorphine is currently the only medicine pharmacists in Queensland can administer by injection.
More comprehensive legislative requirements are outlined within the Injection course.
An innovative and contemporary training course only at PSA, to respond to emerging health needs.
Pharmacists administering medicines by injection must be familiar with the products they can administer to patients. This course currently includes additional injectable product familiarisation modules: Cosentyx, Hyrimoz, Xolair, Ozempic and we will continue developing new modules in the near future.